These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15057673)

  • 21. Is pycnogenol a double-edged sword? Cataractogenic in vitro, but reduces cataract risk in diabetic rats.
    Trevithick JR; Bantseev V; Hirst M; Dzialoszynski TM; Sanford ES
    Curr Eye Res; 2013 Jul; 38(7):751-60. PubMed ID: 23537316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats.
    de la Cruz JP; Moreno A; Mérida F; García-Campos J; Sánchez de la Cuesta F
    Pharmacol Toxicol; 1994 Nov; 75(5):250-4. PubMed ID: 7870694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cataracts in moderately diabetic rats by aminoguanidine.
    Swamy-Mruthinti S; Green K; Abraham EC
    Exp Eye Res; 1996 May; 62(5):505-10. PubMed ID: 8759519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function.
    Birrell AM; Heffernan SJ; Ansselin AD; McLennan S; Church DK; Gillin AG; Yue DK
    Diabetologia; 2000 Jan; 43(1):110-6. PubMed ID: 10672451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D; Mirrlees DJ; Harrison HE; Earl DC
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lutein prevents cataract development and progression in diabetic rats.
    Arnal E; Miranda M; Almansa I; Muriach M; Barcia JM; Romero FJ; Diaz-Llopis M; Bosch-Morell F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jan; 247(1):115-20. PubMed ID: 18766362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
    Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
    J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibition of lipid peroxidation in erythrocytes by aminoguanidine, resorcylidine aminoguanidine and their oxygen and sulfur analogs in diabetic rats].
    Hrnciarová M; Cársky J; Jakuś V; Zlatos L; Kucharská J; Gvozdjáková A
    Bratisl Lek Listy; 1998 Jul; 99(7):364-7. PubMed ID: 9748726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of diabetes and cataract by Na3VO4 plus U-83836E in streptozotocin treated rats.
    Ugazio G; Bosia S; Burdino E; Grignolo F
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):313-28. PubMed ID: 7827806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lens.
    Manikandan R; Thiagarajan R; Beulaja S; Chindhu S; Mariammal K; Sudhandiran G; Arumugam M
    Chem Biol Interact; 2009 Oct; 181(2):202-9. PubMed ID: 19481068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Dines K; Love A
    Diabetologia; 1992 Oct; 35(10):946-50. PubMed ID: 1451951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Reiser KM; Williamson JR; Tilton RG
    Diabetes; 1996 Mar; 45(3):284-90. PubMed ID: 8593931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nifedipine on severe experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Apr; 106(4):651-8. PubMed ID: 18431041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptozotocin-induced diabetes.
    Kedziora-Kornatowska KZ; Luciak M; Błaszczyk J; Pawlak W
    Clin Chim Acta; 1998 Nov; 278(1):45-53. PubMed ID: 9877123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats.
    Ihm SH; Yoo HJ; Park SW; Ihm J
    Metabolism; 1999 Sep; 48(9):1141-5. PubMed ID: 10484054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.
    Sagara M; Satoh J; Wada R; Yagihashi S; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T
    Diabetologia; 1996 Mar; 39(3):263-9. PubMed ID: 8721770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.